Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes
- Shixiang Wang 1,2,3, Huimin Li 1,2,3, Minfang Song 1,2,3, Ziyu Tao 1,2,3, Tao Wu 1,2,3, Zaoke He 1,2,3, Xiangyu Zhao 1,2,3, Kai Wu 4, Xue-Song Liu 1
- Shixiang Wang 1,2,3, Huimin Li 1,2,3, Minfang Song 1,2,3
- 1School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
- 2Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
- 3University of Chinese Academy of Sciences, Beijing, China.
- 4Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- 0School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new bioinformatics tool, sigminer, aids in analyzing copy number alterations in cancer. This tool identified five copy number signatures in prostate cancer, revealing tumor heterogeneity and potential biomarkers for improved prognosis.
Area Of Science
- Genomics
- Bioinformatics
- Cancer Research
Background
- Genome alteration signatures offer insights into cancer evolution.
- Single base substitution (SBS) signatures are well-studied, but tools for copy number alteration (CNA) signatures are lacking.
- CNAs are key drivers in cancer progression.
Purpose Of The Study
- To develop a user-friendly bioinformatics tool for CNA signature extraction, analysis, and visualization.
- To apply the tool to prostate cancer (PC) to identify and characterize CNA signatures.
- To explore the utility of CNA signatures for understanding PC heterogeneity and clinical outcomes.
Main Methods
- Development of the open-source bioinformatics tool "sigminer" for CNA signature analysis.
- Application of sigminer to human PC genomes.
- Identification and illustration of underlying mutational processes for each CNA signature.
- Clustering of PC samples based on CNA signature exposure.
Main Results
- Identification of five distinct CNA signatures in human PC.
- Illustration of the mutational processes driving each identified CNA signature.
- Demonstration of significant PC heterogeneity through sample clustering based on CNA signatures.
- CNA signatures showed a stronger association with PC clinical outcomes compared to SBS signatures.
Conclusions
- The sigminer tool facilitates the study of CNA signatures.
- CNA signature analysis provides novel insights into PC etiology and heterogeneity.
- CNA signatures may serve as potential biomarkers for PC stratification and prognosis.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

